Ghias Babar bought BCRX
July 24, 2025 · Form 4 insider transaction
Ghias Babar bought 305,000 shares of BioCryst Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
305,000
Price
$0.00
Total value
N/A
InsiderGhias Babar
Role—
SecurityEmp. Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJuly 24, 2025
Filing dateJuly 28, 2025
Shares owned after305,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Inducement grant of employee stock options pursuant to the Stock Incentive Plan, which will become exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.